IRIS - Res&Arch Institutional Research Information System - Research & Archive

DE SOCIO, GIUSEPPE VITTORIO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.957
NA - Nord America 2.289
EU - Europa 1.599
SA - Sud America 1.027
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.163
SG - Singapore 1.179
BR - Brasile 763
VN - Vietnam 463
CN - Cina 394
IT - Italia 294
HK - Hong Kong 268
RU - Federazione Russa 250
KR - Corea 196
IE - Irlanda 194
FR - Francia 181
DE - Germania 154
SE - Svezia 141
UA - Ucraina 124
BD - Bangladesh 92
AR - Argentina 90
GB - Regno Unito 77
IN - India 70
FI - Finlandia 66
TR - Turchia 56
CA - Canada 49
EC - Ecuador 49
MX - Messico 47
ID - Indonesia 42
IQ - Iraq 38
CO - Colombia 36
VE - Venezuela 29
AT - Austria 26
ZA - Sudafrica 25
PK - Pakistan 19
JP - Giappone 17
PL - Polonia 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
MA - Marocco 16
NL - Olanda 16
CL - Cile 15
PY - Paraguay 15
PH - Filippine 14
ES - Italia 13
PE - Perù 13
EG - Egitto 11
LB - Libano 11
JO - Giordania 10
BO - Bolivia 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
KE - Kenya 7
MY - Malesia 7
RO - Romania 7
DZ - Algeria 6
UY - Uruguay 6
AL - Albania 5
BE - Belgio 5
GR - Grecia 5
JM - Giamaica 5
LT - Lituania 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
ET - Etiopia 4
GA - Gabon 4
GT - Guatemala 4
IL - Israele 4
OM - Oman 4
TH - Thailandia 4
TN - Tunisia 4
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
SD - Sudan 3
SN - Senegal 3
AU - Australia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HN - Honduras 2
HU - Ungheria 2
ML - Mali 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BT - Bhutan 1
BY - Bielorussia 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
LV - Lettonia 1
Totale 7.959
Salva come PNG Salva come JPEG
Città #
Singapore 781
Hong Kong 266
San Jose 224
Seoul 195
Chandler 193
Dublin 192
Ashburn 163
Ho Chi Minh City 154
Lauterbourg 127
Columbus 99
Piscataway 93
Moscow 91
San Mateo 86
Hanoi 81
Santa Clara 79
Beijing 76
São Paulo 73
Dong Ket 67
New York 65
Boardman 63
Jacksonville 58
Perugia 58
Munich 55
Altamura 54
Los Angeles 49
Medford 45
Princeton 45
Wilmington 39
Lawrence 38
Ann Arbor 33
Council Bluffs 33
Rio de Janeiro 33
Hefei 30
The Dalles 30
Helsinki 26
Des Moines 24
Dallas 23
Mexico City 22
Nuremberg 21
Falls Church 20
Frankfurt am Main 20
Haiphong 20
Milan 19
Andover 17
Guayaquil 17
Chennai 16
Curitiba 16
Montreal 16
Orem 16
Tokyo 16
Baghdad 15
Denver 15
Houston 15
Turku 15
Amsterdam 14
Florence 14
Quito 13
Rome 13
Toronto 13
Vienna 13
Warsaw 13
Caracas 12
Padova 12
Porto Alegre 12
Tashkent 12
Ankara 11
Belo Horizonte 11
Guangzhou 11
Guarulhos 11
Medellín 11
Ninh Bình 11
Poplar 11
Riyadh 11
Bologna 10
Boston 10
Brasília 10
Brooklyn 10
Buffalo 10
Falkenstein 10
Izmir 10
London 10
Norwalk 10
Salvador 10
Woodbridge 10
Atlanta 9
Campinas 9
Da Nang 9
Dhaka 9
Johannesburg 9
Manaus 9
Mersin 9
Stockholm 9
Amman 8
Biên Hòa 8
Hải Dương 8
Istanbul 8
Jakarta 8
Phoenix 8
Redmond 8
Thái Bình 8
Totale 4.612
Salva come PNG Salva come JPEG
Nome #
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 165
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. 149
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 141
Accelerate Pheno™ blood culture detection system: a literature review 132
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 127
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 124
Achromobacter denitrificans renal abscess. 122
Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli 113
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 113
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 108
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 108
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 104
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 102
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 100
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 98
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 97
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 95
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 95
[Loa loa filariasis in Italy: review of the literature with a clinical report] 93
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics. 92
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 90
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 86
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 85
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 85
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 84
XVI Convegno Nazionale AIDS e SINDROMI CORRELATE 82
Infezioni da Cytomegalovirus nel paziente immunodepresso. 82
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. 82
Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort 82
Smoking habits in HIV-infected people compared with the general population in Italy: A cross-sectional study 82
Lingual tubercolosis: a rare disease in western countries 81
Negative influence of HIV infection on day-night blood pressure variability. 78
An unusual case of epigastric and back pain: expanding descending thoracic aneurysm resulting from tertiary syphilis diagnosed with positron emission tomography. 77
Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection 75
Le infezioni da Cytomegalovirus ed il loro trattamento nel paziente immunodepresso (AIDS e TMO). 73
HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness? 69
Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast® 69
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 67
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 64
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 63
Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica 63
Observed versus predicted cardiovascular events and all-cause death in HIV infection: A longitudinal cohort study 61
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 61
Laboratory automation, informatics, and artificial intelligence: current and future perspectives in clinical microbiology 59
AmBisome administration for Candida albicans shunt infections 59
Retroperitoneal abscess: an uncommon localization of tubercular infection. 57
Bictegravir and Dolutegravir have no impact on glucose levels 12 months after initiation 56
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 55
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study 54
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study 54
Antiretroviral therapy and adverse skeletal effects 53
Thrombocytopenia in HIV infected patients: prevalence and clinical spectrum 53
Liver enzyme variation after switching to emtricitabine/tenofovir alafenamide/bictegravir is associated with glucose increase in a real-life cohort 52
Real-life monocentric Biktarvy cohort from Perugia 52
Giant Infective Endocarditis of Native Aortic Valve with Secondary Mitral Kissing Vegetation 52
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 52
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir] 52
[Low incidence of streptococcal pharyngitis in young adults] 50
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. 50
Ageing with HIV: a multidisciplinary review 48
HIV Infection - Screening, Diagnosis, and Treatment 48
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 48
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 48
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 48
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 47
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 47
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 46
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing 46
Knowledge of STIs and HIV among people with and without HIV: where are we now? 46
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 45
Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required 44
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 44
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 43
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data 43
Schizophrenia, drug therapy, and monitoring 42
Reversibility of Central Nervous System Adverse Events in Course of Art 42
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 41
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians 41
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 41
Adefovir induced hypophosphatemic osteomalacia 40
Safety and efficacy of switching people with HIV to dual treatment with 3TC/DTG and RPV/DTG in real life: results from the SCOLTA cohort 40
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 39
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 39
Factors Associated With Weight Gain in People Treated With Dolutegravir 39
Relations between cardiovascular risk estimates and subclinical atherosclerosis in naı¨ve HIV patients: results from the HERMES study 39
With or without TAF? What is the difference? Data from a real-life setting 39
Waist circumference and body mass index in HIV infection 39
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 38
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 38
UV-C Irradiation Effectiveness on Mpox-Virus-Contaminated Surfaces 38
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 38
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 37
Il fumo di sigaretta, un fattore di rischio maggiore per la popolazione HIV-positiva: strategie di intervento 37
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 36
Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study 36
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 36
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA) 35
[Nosocomial infections in a general surgical ward] 35
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study 35
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 35
Totale 6.565
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/2022362 9 58 10 25 18 15 7 91 13 13 47 56
2022/2023675 48 130 11 54 44 83 9 23 246 0 16 11
2023/2024267 11 32 14 5 4 1 69 3 23 11 50 44
2024/20251.311 9 66 24 28 75 47 54 55 213 277 199 264
2025/20265.068 308 385 449 1.174 422 231 614 316 493 410 181 85
Totale 8.281